Clinical Operations in Oncology Trials Europe 2022 Today starts Clinical Operations in Oncology Trials Europe. APICES is speaking about why medium/regional CROs are the best choice in Oncology trials. Clinical Operations in Oncology Trials Europe 2022
Clinical Operations in Oncology Trials Europe 2022 APICES is actively participating in the upcoming CLINICAL OPERATIONS IN ONCOLOGY TRIALS EUROPE 2022 congress in Zurich. In the following link you can access the agenda. Clinical Operations in Oncology Trials…
Acknowledgement for APICES collaboration in INMUNOSUN study published in “ESMO Open” We are privileged to share the acknowledgment that APICES has received in the recent publication titled: “Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of…
Acknowledgment for APICES collaboration in a GICOR trial published in Radiotherapy and Oncology From APICES, we are privileged to share the acknowledgment that we have received in the recent publication titled “Prognostic value of testosterone castration levels following…
CLINICAL TRIALS REGULATION (EU) 536/2014 IMPLEMENTATION TRAINING Last month, The European Commission, Clinical Trials Facilitation and Coordination Group and European Medicines Agency (EC-DG SANTE/HMA-CTFG/EMA) imparted a joint training on the Clinical Trials Regulation (EU) 536/2014. The implementation to…
New regulation for observational studies with medicines for human use in Spain Last week, the Royal Decree 957/2020 which regulates the observational studies with medicines for human use was published in the BOE. This regulation will come into…
Acknowledgment for APICES collaboration in DUTRENEO study presented as ORAL PRESENTATION at ASCO 2020 Annual Meeting. We want to share the acknowledgment that APICES has received in a recent ORAL PRESENTATION at the ASCO 2020 Annual Meeting by Dr. Enrique Grande. APICES…
Acknowledgment for APICES collaboration in a clinical trial published in Scientific Reports. This month, we want to share the acknowledgment that APICES has received in a recent publication in Scientific Reports in which APICES has collaborated in several…
Acknowledgment for APICES collaboration in a clinical trial published in BMC Cancer. This month, we want to share the acknowledgment that APICES has received in a recent publication in BMC Cancer in which APICES has collaborated in several…
EMA AND FDA MARKETING AUTHORIZATIONS: CONCORDANCES AND DISCORDANCES EMA and FDA have published in joint an article entitled “A comparison of EMA and FDA decisions for new drug marketing applications 2014-2016: concordance, discordance and why”. Most of information…
